First Time Loading...

ABVC Biopharma Inc
NASDAQ:ABVC

Watchlist Manager
ABVC Biopharma Inc Logo
ABVC Biopharma Inc
NASDAQ:ABVC
Watchlist
Price: 1.08 USD -6.09% Market Closed
Updated: May 5, 2024

ABVC Biopharma Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ABVC Biopharma Inc
Cash from Operating Activities Peer Comparison

Comparables:
AMGN
ALNY
KRTX
MRNA
SRPT

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
ABVC Biopharma Inc
NASDAQ:ABVC
Cash from Operating Activities
-$4.2m
CAGR 3-Years
2%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash from Operating Activities
$8.5B
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
3%
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Cash from Operating Activities
$104.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Karuna Therapeutics Inc
NASDAQ:KRTX
Cash from Operating Activities
-$385.8m
CAGR 3-Years
-77%
CAGR 5-Years
-90%
CAGR 10-Years
N/A
Moderna Inc
NASDAQ:MRNA
Cash from Operating Activities
-$3.1B
CAGR 3-Years
N/A
CAGR 5-Years
-57%
CAGR 10-Years
N/A
Sarepta Therapeutics Inc
NASDAQ:SRPT
Cash from Operating Activities
-$533.7m
CAGR 3-Years
9%
CAGR 5-Years
-1%
CAGR 10-Years
-21%

See Also

What is ABVC Biopharma Inc's Cash from Operating Activities?
Cash from Operating Activities
-4.2m USD

Based on the financial report for Dec 31, 2023, ABVC Biopharma Inc's Cash from Operating Activities amounts to -4.2m USD.

What is ABVC Biopharma Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-36%

Over the last year, the Cash from Operating Activities growth was 43%. The average annual Cash from Operating Activities growth rates for ABVC Biopharma Inc have been 2% over the past three years , -36% over the past five years .